ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biological role of long non-coding RNA KCNQ1OT1 in cancer progression

Zhan, Kai; Pan, Huafeng; Zhou, Zhang; Tang, Wenqian; Ye, Zhining; Huang, Shaogang; Luo, Lei*广州中医药大学
Biomedicine and Pharmacotherapy2023-12-31DOI: 10.1016/j.biopha.2023.115876
6阅读
引用收藏
分享

摘要

Long non-coding RNAs (lncRNAs) are a type of RNAs that are more than 200 nucleotides without protein-coding potential. In recent years, more and more attention has been paid to the role of lncRNAs in cancer pathogenesis. LncRNA KCNQ1 overlapping transcript 1 (KCNQ1OT1) is located on chromosome 11p15.5 with a total length of 91 kb and is highly expressed in various malignancies, which is closely related to tumor growth, lymph node metastasis, survival cycle and recurrence rate. In addition, KCNQ1OT1 is involved in the regulation of PI3K/AKT and Wnt/beta-catenin signaling pathways. In this review, the mechanism and related progress of KCNQ1OT1 in different cancers were reviewed. It was found that KCNQ1OT1 can stabilize mRNA expression through sponging miRNA, which not only induced tumor cell proliferation, migration, invasion, drug resistance, epithelialmesenchymal transition (EMT) and inhibited cell apoptosis in vitro, but also promoted tumor growth and metastasis in vivo. Therefore, as a new biomarker and therapeutic target, KCNQ1OT1 has broad prospects for the diagnosis and treatment of different cancers.

学科与关键词

关键词
Long noncoding RNAKCNQ1OT1CancerSignaling pathwayProgression
相关
加载中…
  • LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
    Xia, Fangqi; Wang, Yaqi; Xue, Mengzhen; Zhu, Leiqi; Jia, Dengke; Shi, Yue; Gao, Yan; Li, Luoying; Li, Yuanyang; Chen, Silong; Xu, Guangfu; Yuan, Ding*; Yuan, Chengfu*Genes & Diseases, 2022, 9(6): 1556-1565.被引 7
  • KCNQ1OT1在肿瘤中的表达及意义
    胡增涛; 徐书婉; 夏浩明; 高泽玮; 黄荣菊; 唐恩雨; 姜兴明实用药物与临床, 2019, (11): 1226-1229.
  • Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition
    Li, Deyu; Tong, Qin; Lian, Yuane; Chen, Zhizhong; Zhu, Yaru; Huang, Weimei; Wen, Yang; Wang, Qiongyao; Liang, Shumei; Li, Man; Zheng, Jianjing; Liu, Zhenhua*; Liu, Huanxin*; Guo, Linlang*Cancer Research and Treatment, 2021, 53(4): 1042-1056.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2023-12-31
卷期
第 169 卷
页码
115876
DOI
10.1016/j.biopha.2023.115876
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Dongguan Social Development Science and Technology Project (2023 High level Hospital Construction Special Project) [20231800918372]; Wuhan Knowledge Innovation Project [2023020201020518]

作者

  • Z

    Zhan, Kai (第一作者)

    guangzhou univ chinese med

  • P

    Pan, Huafeng

    guangzhou univ chinese med

查看全部 7 位作者收起作者
  • Z

    Zhou, Zhang

  • T

    Tang, Wenqian

    hubei prov hosp tradit chinese med

  • Y

    Ye, Zhining

    guangzhou univ chinese med

  • H

    Huang, Shaogang

    2 · guangzhou univ chinese med

  • L

    Luo, Lei (通讯)

    hubei prov hosp tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417